LH · Labcorp Holdings Inc.
$273.722026-05-17Sector: Healthcare; Industry: Medical - Diagnostics & Research; Sub-Industry: Health Care Services
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$105
-61.5% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($105 · $108) Analysts Range ($300 · $342) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2021.Q4 | $13.1B | — | 23.2% | 23.9% | $2.3B | −$460MM | $1.9B | 7.1% | — | 16.1% | $14.4B | $28.57 | — |
| 2022.Q4 | $11.9B | -9.7% | 12.1% | 18.1% | $1.2B | −$1.6B | −$444MM | 8.2% | — | 7.9% | $15.3B | $15.37 | — |
| 2023.Q4 | $12.2B | 2.5% | 6.0% | 33.1% | $485MM | −$956MM | −$471MM | 7.8% | — | 3.5% | $12.6B | $5.02 | — |
| 2024.Q4 | $13.0B | 7.0% | 8.4% | 22.1% | $846MM | −$787MM | $59MM | 8.5% | — | 6.6% | $13.1B | $8.97 | — |
| 2025.Q4 | $14.0B | 7.2% | 10.7% | 20.7% | $1.2B | −$861MM | $327MM | 8.5% | — | 8.6% | $14.6B | $10.53 | 15.2 |
| italics below = DCF projection · 10yr Rev CAGR: 5.5% |
| 2026.Q4 | $14.7B | +5.2% | 10.8% | 20.7% | $1.3B | −$765MM | $496MM | 8.9% | $455MM | 8.4% | $15.3B | $15.16 | 18.1 |
| 2027.Q4 | $15.4B | +4.8% | 11.2% | 20.6% | $1.4B | −$766MM | $604MM | 8.9% | $509MM | 8.7% | $16.1B | $16.46 | 16.6 |
| 2028.Q4 | $16.2B | +5.2% | 12.2% | 20.5% | $1.6B | −$868MM | $703MM | 8.9% | $544MM | 9.5% | $16.9B | $18.89 | 14.5 |
| 2029.Q4 | $17.3B | +7.2% | 12.2% | 20.4% | $1.7B | −$1.3B | $384MM | 8.8% | $273MM | 9.5% | $18.2B | $20.18 | 13.6 |
| 2030.Q4 | $18.5B | +6.7% | 12.2% | 20.4% | $1.8B | −$1.3B | $481MM | 8.8% | $314MM | 9.5% | $19.6B | $21.55 | 12.7 |
|
| Term. Yr+ | $24.7B | 4.1% | 10.9% | 20.0% | $2.1B | −$1.0B | $1.1B | 8.6% | $10.7B | 8.6% | — | — | — |
Active scenario IV: $105 (-61.5% vs market)